Press release
Microcrystalline Cellulose (MCC) Market: Growing Demand, Leading Innovators, and Future Outlook to 2030
The Microcrystalline Cellulose (MCC) market is witnessing steady growth driven by rising demand in food, pharmaceuticals, and personal care industries. Key companies like DuPont, DFE Pharma, Asahi Kasei, and FMC Corporation are focusing on product innovation and regional expansion to meet evolving consumer and industrial needs, shaping a competitive global landscape.The Microcrystalline Cellulose (MCC) Market is projected to grow from USD 1.33 billion in 2025 to USD 1.88 billion by 2030, at a CAGR of 7.1% during the forecast period. The report includes information on market trends and development, microcrystalline cellulose market growth [https://www.marketsandmarkets.com/Market-Reports/microcrystalline-cellulose-market-59144224.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=microcrystallinecellulose] drivers, emerging technologies, and the investment structure of the market. The market for microcrystalline cellulose is influenced by several primary factors, such as the existence of numerous manufacturers, government support, and increased microcrystalline cellulose production. Due to its exceptional properties such as excellent compressibility and binding capacity, high water-holding capacity and moisture retention makes it an essential material in applications such as pharmaceutical, food & beverage, and cosmetics & personal care. Microcrystalline cellulose exhibits outstanding compressibility, allowing it to form strong, cohesive compacts without the need for binders. This property is essential for tablet formulation in pharmaceuticals, ensuring tablets are robust enough to withstand handling and transportation. Microcrystalline cellulose is chemically inert, non-reactive with other formulation components, and stable under various conditions. It is not digested by the human body, passes through the system as insoluble dietary fiber, and does not contribute calories, making it ideal for low-calorie and dietary fiber-fortified foods.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=59144224 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=59144224&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=microcrystallinecellulose]
Wood dominated the source segment in terms of value in the microcrystalline cellulose market.
Wood is considered to be the most preferred source for manufacturing microcrystalline cellulose primarily due to its high and consistent cellulose content, established processing methods, and the superior quality of the resulting microcrystalline cellulose. Wood pulp, especially from softwood and hardwood sources, contains a high percentage of alpha cellulose, which is essential for producing microcrystalline cellulose with excellent physical properties such as bulk density, flowability, and compressibility. The cellulose chains in wood are closely packed and held together by strong hydrogen bonds, resulting in a highly crystalline structure that is ideal for microcrystalline cellulose production.
The process of extracting microcrystalline cellulose from wood pulp is well-established and has been refined over more than 70 years, making it both reliable and scalable for industrial production. The Kraft and sulphite pulping methods efficiently remove lignin and hemicellulose, yielding purified cellulose that can be consistently hydrolysed to produce high-quality microcrystalline cellulose.
Microcrystalline cellulose derived from wood exhibits excellent binding and compressibility, which are critical for its primary use as a binder and disintegrant in pharmaceutical tablet formulations. The plasticity and particle structure of wood based microcrystalline cellulose make it particularly effective in direct compression processes.
Pharmaceutical application accounted for the largest share in the application segment in terms of value in the microcrystalline cellulose market.
Pharmaceutical application accounted for the largest share of the global microcrystalline cellulose market in 2024. Microcrystalline cellulose is a key excipient in pharmaceutical tablet and capsule formulations. Its excellent binding, compressibility, and disintegration properties make it indispensable for producing tablets with uniform drug distribution, consistent release profiles, and reliable mechanical strength. Microcrystalline cellulose is used in a wide range of pharmaceutical products, including quick-release tablets, sustained-release multiparticulates, matrix tablets, chewable, and effervescent tablets. Its ability to function as a binder, filler, and disintegrant enhances the efficiency and quality of drug delivery systems. Microcrystalline cellulose meets stringent regulatory requirements for safety, efficacy, and quality, making it the preferred choice for pharmaceutical manufacturers worldwide. Regulatory bodies such as the FDA and EMA recognize microcrystalline cellulose as a safe and effective excipient, further driving its adoption.
Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=59144224 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=59144224&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=microcrystallinecellulose]
North America accounted for the largest share of the microcrystalline cellulose market in terms of value and volume.
North America accounted for the largest share of the microcrystalline cellulose market with the US leading the market in the region. The growth in the microcrystalline cellulose market in this region is driven mainly by its use in pharmaceutical excipients, food & beverage, and cosmetic & personal care industries. The pharmaceutical application accounted for the maximum market share in the North American microcrystalline cellulose market, in terms of value, in 2024. The largest share of the application in the North American microcrystalline cellulose market is mainly attributed to the presence of a large number of global pharmaceutical giants, such as Pfizer (US), Abbott Laboratories (US), and Johnson & Johnson (US), in this region.
Microcrystalline Cellulose Companies [https://www.marketsandmarkets.com/ResearchInsight/microcrystalline-cellulose-market.asp?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=microcrystallinecellulose]
Prominent companies include Asahi Kasei Corporation (Japan), Rayonier Advanced Materials (RYAM, US), Sigachi Industries (India), DFE Pharma (Germany), International Flavors & Fragrances Inc. (New York), Accent Microcell Ltd. (India), Mingtai Chemical Co., Ltd. (China), Chemfield Cellulose (India), Anhui Sunhere Pharmaceutical Excipients Co., Ltd. (China), Roquette Freres (France), J. Rettenmaier & Sohne GmbH + Co. Kg (JRS Pharma, Germany), RanQ (India), and Huzhou City Linghu Xinwang Chemical Co., Ltd. (China).
Asahi Kasei Corporation (Japan)
Asahi Kasei Corporation is involved in manufacturing organic and inorganic industrial chemicals, polymers, performance materials, petrochemicals, and other consumer products. The company operates through three main segments: material, homes, and healthcare. Asahi supplies microcrystalline cellulose through its healthcare segment. The company's operating bases are strategically located around the world to ensure efficient supply of products and services in North America, Europe, and Asia Pacific.
International Flavors & Fragrances Inc. (US)
International Flavors & Fragrances Inc. (IFF) is a leading global company that specializes in manufacturing and distributing flavors, fragrances, and ingredients for various industries, including food, beverages, health, biosciences, and pharmaceuticals. The company has four reportable segments: Nourish, Health & Biosciences, Scent, and Pharma Solutions. International Flavors & Fragrances Inc. offers microcrystalline cellulose through its Pharma Solutions segment.
The group operates in 65 countries, with a diverse presence across Asia Pacific, Europe, the Middle East & Africa, North America, and South America. IFF maintains over 100 research & development centres globally, supporting innovation and customer collaboration.
Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=59144224 [https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=59144224&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=microcrystallinecellulose]
Roquette Freres (France)
Roquette Freres is a global leader in plant-based ingredients and a top provider of pharmaceutical excipients. Working with its customers and partners, the group tackles current and future societal challenges by harnessing nature's potential to deliver the best ingredients for food, nutrition, and health markets. The company conducts its business through two main reportable segments: Pharma Solutions and Key Ingredients, with microcrystalline cellulose products marketed under the pharma solutions division segment.
About MarketsandMarkets Trademark
MarketsandMarkets Trademark has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets Trademark is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore Trademark (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=microcrystalline-cellulose-mcc-market-growing-demand-leading-innovators-and-future-outlook-to-2030]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/microcrystalline-cellulose-market-59144224.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Microcrystalline Cellulose (MCC) Market: Growing Demand, Leading Innovators, and Future Outlook to 2030 here
News-ID: 4117124 • Views: …
More Releases from ABNewswire
Martal Group Highlights Expanding Industry Expertise Across Technology, SaaS, He …
The company showcases sector-specific lead generation programs that help B2B teams capture qualified opportunities in fast-evolving, competitive markets.
Martal Group is spotlighting its growing industry footprint as demand rises for specialized, AI-supported B2B lead generation. Companies across technology, SaaS, healthcare, cybersecurity, and solar now turn to Martal's outreach teams for predictable pipeline and sector-aware prospecting that moves beyond generic sales development.
Teams in each vertical face shifting market pressures, from longer buying…
Rheumatoid Arthritis Market to Grow Significantly from ~20 Billion Over the Next …
The Key Rheumatoid Arthritis Companies in the market include - R-Pharm, Taisho Pharmaceuticals, GlaxoSmithKline, Aclaris Therapeutics, Bristol Myers Squibb, Eli Lilly, Taiho Pharmaceutical, Cyxone, Gilead Sciences, Kiniksa Pharmaceuticals, Istesso, Applied Molecular Transport, Horizon Therapeutics, Genosco (Oscotec), Hope Biosciences, Abivax, Mesoblast, Pfizer, Akros Pharma/Japan Tobacco, Pfizer/Philogen, AbbVie, Pfizer, SynAct Pharma, and others.
The Rheumatoid Arthritis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period.…
Gastrointestinal Stromal Tumor Market to Grow Rapidly Over the Next Decade, Delv …
The Key Gastrointestinal Stromal Tumor Companies in the market include - Jiangsu Hengrui Medicine, Daiichi Sankyo Company, Cogent Biosciences, Advenchen Laboratories, AB Science, Immunicum AB, Novartis, Bristol-Myers Squibb, Hanmi Pharmaceutical Company Limited, Ascentage Pharma, Array BioPharma, Plexxikon, Arog Pharmaceuticals, Xencor Inc., DNAtrix Inc., Onyx Pharmaceuticals, Exelixis, Allarity Therapeutics, Theseus Pharmaceuticals, IDRx Inc., Allarity Therapeutics, and others.
The Gastrointestinal Stromal Tumor market is expected to surge due to the disease's increasing prevalence…
Acute Coronary Syndrome Market to with a Significant CAGR Through by 2034, Delve …
The Key Acute Coronary Syndrome Companies in the market include - Idorsia Pharmaceuticals, Viatris, Recardio, AstraZeneca, Faraday Pharmaceuticals, DalCor Pharmaceuticals, Roche, Jiangsu Vcare PharmaTech, CeleCor Therapeutics, Novo Nordisk, Bristol Myers Squibb, Johnson & Johnson Innovative Medicine, CellProthera, BioCardia, Kancera, Amgen, Arrowhead Pharmaceuticals, and Abcentra, among others.
The Acute Coronary Syndrome market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage…
More Releases for Microcrystalline
Top 10 Microcrystalline Cellulose Companies Analysis to 2031
Microcrystalline cellulose is a refined wood pulp derivative that appears as a white, odorless, tasteless powder. It is made from cellulose, which is a naturally occurring structural component of plant cell walls.
Microcrystalline Cellulose - a versatile excipient used in pharmaceuticals, food, and cosmetics for its excellent compressibility and binding properties.
Download The Exclusive PDF @ https://www.theinsightpartners.com/sample/TIPRE00004679/?utm_source=OpenPR&utm_medium=10864
Key Companies:
• Accent Microcell Pvt. Ltd.
• Asahi Kasei Corporation
• Avantor, Inc.
• DFE Pharma GmbH and Co.KG
• FMC Corporation
• JRS PHARMA GmbH and…
Microcrystalline Cellulose Market Challenges, Growth and Opportunities - 2031
The microcrystalline cellulose (MCC) market is experiencing steady growth, driven by its diverse applications across various industries. This article provides a detailed analysis of the market landscape, encompassing market size and growth projections, segmentation, regional trends, key drivers and challenges, future outlook, and competitive landscape.
𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐕𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐬𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐨𝐮𝐫 𝐌𝐢𝐜𝐫𝐨𝐜𝐫𝐲𝐬𝐭𝐚𝐥𝐥𝐢𝐧𝐞 𝐂𝐞𝐥𝐥𝐮𝐥𝐨𝐬𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 :https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2455
Microcrystalline cellulose (MCC) is a purified form of cellulose derived from wood pulp. It offers…
Microcrystalline Cellulose Market Demand,Trends, Size 2021-2031
The global Microcrystalline Cellulose market is estimated to attain a valuation of US$ 1.68 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 5.2% during the forecast period, 2021-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders…
Microcrystalline Cellulose Spheres Market 2021 | Detailed Report
Microcrystalline Cellulose Spheres Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Microcrystalline Cellulose Spheres Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4972339
The report provides a comprehensive analysis of company profiles listed below:
- SEPPIC
- JRS Pharma
- NB…
Microcrystalline Wax Market Size, Share, Development by 2022.
LP INFORMATION offers a latest published report on Microcrystalline Wax Market Analysis and Forecast 2017-2022 delivering key insights and providing a competitive advantage to clients through a detailed report.
The Global Microcrystalline Wax market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.
Click to view the full…
Microcrystalline Cellulose Market Trends and Segments 2015-2025
Cellulose is the prime component of plant cell. Microcrystalline cellulose is partially depolymerized cellulose, obtained from wood pulp. It is also formed through some of the fungi, bacteria, algae or marine animals. It is insoluble in water and is primarily used as bulking and anticaking agent in production of food products. It is also used as a texturizer, emulsifier and as an extender in application such as pharmaceutical or personal…
